Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INSPIRE: Interventions for Screening and Treatment of Psychiatric Inpatients With HCV Resulting in Elimination

NCT04625322 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04625322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INSPIRE: Interventions for Screening and Treatment of Psychiatric Inpatients With HCV Resulting in Elimination
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
April 19, 2022
Completion date
April 30, 2023
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c